Country: Ирска
Језик: Енглески
Извор: HPRA (Health Products Regulatory Authority)
CLOSANTEL SODIUM DIHYDRATE, MEBENDAZOLE
Elanco Animal Health, Eli Lilly and Company Limited
QP52A
CLOSANTEL SODIUM DIHYDRATE, MEBENDAZOLE
50 + 75 Mg/Ml
Oral Suspension
LM-Licensed Merchant
Ovine
ANTHELMINTICS
Endoparasiticide
Authorised
2012-06-08
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Flukiver Combi 50 mg/ml + 75 mg/ml oral suspension. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Oral suspension. White to faintly cream-coloured suspension. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Sheep and lambs. Each ml contains: ACTIVE SUBSTANCES: Closantel (as closantel sodium dihydrate) 50 mg Mebendazole 75 mg For the full list of excipients, see section 6.1. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 23/12/2014_ _CRN 7019521_ _page number: 1_ 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of mixed parasitic infestations where the action of both active substances is required. TREMATODES Liver flukes: _Fasciola hepatica _(adults + 5-8 week-immatures) NEMATODES Roundworms _Haemonchus contortus _(adults, immatures, inhibited stages and BZ-resistant strains) _Bunostomum _sp. (adults) _Chabertia ovina _(adults + immatures) _Oesophagostomum _spp. (adults) _Capillaria _spp. (adults) _Cooperia _spp. (adults) _Nematodirus _spp. (adults + immatures) _Teladorsagia circumcincta _(adults + immatures) _Trichostrongylus axei _(adults) _Trichostrongylus colubriformis _(adults + immatures) _Trichostrongylus vitrinus _(adults) Lungworms _Dictyocaulus filaria _(adults + immatures) CESTODES _Avitellina _spp. _Moniezia _spp. ARTHROPODS _Oestrus ovis _(nasal bot) 1st, 2nd and 3rd instar 4.3 CONTRAINDICATIONS Do not administer to animals with known hypersensitivity to the active ingredients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES CARE SHOULD BE TAKEN TO AVOID THE FOLLOWING PRACTICES BECAUSE THEY INCREASE THE RISK OF DEVELOPMENT OF RESISTANCE AND COULD ULTIMATELY RESULT IN INEFFECTIVE THERAPY: · Too freque Прочитајте комплетан документ